~~<i id='A6986D61EC'><strike id='A6986D61EC'><tt id='A6986D61EC'><pre id='A6986D61EC'></pre></tt></strike></i>~~

Home» comprehensive» leisure time

leisure time

author：comprehensive 2025-09-28 16:39:07 Page View：41593

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： A new drug could help frostbite victims avoid its ravages
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

knowledge

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Female surgeons have lower rates of long

AdobeAnewstudypublishedWednesdayinJAMASurgerysuggeststhatpatientstreatedbyfemalesurgeonshavelowerrat

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

HasPhRMAlostitsfangs?Are11th-hourchangesominousforclinicaltrials?Andwhat’snextinpainmedicine?Wecover